LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 37.71 | 27.76 | 2228 | 2877 | 0.7742 | 0.9250 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 39.41 | 27.76 | 43 | 3105 | 0.0138 | 0.0664 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 39.41 | 27.76 | 2197 | 3105 | 0.7074 | 0.9008 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 39.41 | 27.76 | 2280 | 3105 | 0.7342 | 0.9112 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 39.41 | 27.76 | 2377 | 3105 | 0.7654 | 0.9230 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 41.11 | 27.76 | 54 | 3331 | 0.0162 | 0.1011 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 41.11 | 27.76 | 2354 | 3331 | 0.7066 | 0.9019 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 41.11 | 27.76 | 2379 | 3331 | 0.7141 | 0.9048 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 41.11 | 27.76 | 2475 | 3331 | 0.7429 | 0.9158 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 42.81 | 27.76 | 68 | 3596 | 0.0189 | 0.1362 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 42.81 | 27.76 | 2480 | 3596 | 0.6896 | 0.8968 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 42.81 | 27.76 | 2497 | 3596 | 0.6943 | 0.8987 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 42.81 | 27.76 | 2604 | 3596 | 0.7241 | 0.9101 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 44.52 | 27.76 | 78 | 3884 | 0.0201 | 0.1560 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 44.52 | 27.76 | 2670 | 3884 | 0.6874 | 0.8976 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 44.52 | 27.76 | 2697 | 3884 | 0.6943 | 0.9002 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 44.52 | 27.76 | 2806 | 3884 | 0.7224 | 0.9108 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 46.22 | 27.76 | 94 | 4125 | 0.0228 | 0.1842 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 46.22 | 27.76 | 2835 | 4125 | 0.6873 | 0.8987 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 46.22 | 27.76 | 2885 | 4125 | 0.6994 | 0.9033 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 46.22 | 27.76 | 2966 | 4125 | 0.7190 | 0.9106 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 47.93 | 27.76 | 111 | 4421 | 0.0251 | 0.2086 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 47.93 | 27.76 | 3033 | 4421 | 0.6860 | 0.8996 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 47.93 | 27.76 | 2974 | 4421 | 0.6726 | 0.8945 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 47.93 | 27.76 | 3122 | 4421 | 0.7061 | 0.9071 | MN20160318_Q01 | E11 |